Morningstar has reiterated its 'BUY' rating for Veeva Systems Incorporated (NYSE: VEEV), underscoring the company's strong earnings performance and robust growth prospects.
AskGamblers, a leading name in the online gambling review space, has expanded its offerings by launching a new live scores feature tailored to the needs of sports fans and bettors.
Biocon share price jumped nearly 4 percent during early trades as the company received FDA approval for biosimilar drug Yesintek. Biocon touched intraday high of Rs 380 after opening at Rs 375.